Zhen Su

Chief Medical Officer for North America


Profile

Zhen Su, MD, MBA, is the Chief Medical Officer for North America at EMD Serono.

In this role, Zhen is responsible for working with the local and global medical, development and regulatory teams to lead EMD Serono's medical strategy, clinical presence and scientific leadership in the U.S.

Within EMD Serono, he most recently held the position of Global Head of Medical Affairs, Oncology, prior to which, he held leadership roles in general management, clinical development and medical affairs at Sanofi and GlaxoSmithKline.

A physician executive with more than 20 years of experience, Zhen held roles at a number of academic institutions - including at Duke University and University of Florida, where he led early clinical development in Immuno-Oncology as a faculty member - before joining the biopharmaceutical industry.

Zhen earned his MD degree from the Technical University of Dresden, Germany and completed his MBA training at the University of Toronto, Canada.

Redirect

You have accessed https://www.emdgroup.com, but for users from your part of the world, we originally designed the following web presence https://www.merckgroup.com.

Let's go

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement